SCHEMBL25663149

SCHEMBL25663149

c1ccc2c(c1)sc1c(-c3ccc4cc(N(c5ccc(-c6ccc7cnccc7c6)cc5)c5ccc(-c6ccc7cnccc7c6)cc5)ccc4c3)ncnc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LIMK1 P53667 10/20 0.40
▸ CDK5 Q00535 1/20 0.38
▸ CDK5R1 Q15078 1/20 0.38
▸ TDO2 P48775 1/20 0.36
▸ AKT1 P31749 1/20 0.36
▸ MAPK9 P45984 1/20 0.35
▸ MAPK10 P53779 1/20 0.35
▸ HTR2C P28335 1/20 0.35
▸ HRH4 Q9H3N8 1/20 0.35
▸ PIK3CA P42336 2/20 0.34
▸ EGFR P00533 4/20 0.33
▸ PIK3CD O00329 1/20 0.33
▸ ABL1 P00519 1/20 0.33
▸ HCK P08631 1/20 0.33
▸ SRC P12931 1/20 0.33
▸ KDR P35968 1/20 0.33
▸ PIK3CB P42338 1/20 0.33
▸ MTOR P42345 1/20 0.33
▸ PIK3CG P48736 1/20 0.33
▸ EPHB4 P54760 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25663150 0.97 LIMK1 (0.39) LIMK1CDK5CDK5R1TDO2AKT1
SCHEMBL25663157 0.91 LIMK1 (0.35) LIMK1CDK5CDK5R1TDO2AKT1
SCHEMBL25663488 0.91 LIMK1 (0.36) LIMK1CDK5CDK5R1TDO2AKT1
SCHEMBL25663156 0.88 MAP4K4 (0.37) LIMK1CDK5CDK5R1MAPK9MAPK10
SCHEMBL25663155 0.88 LIMK1 (0.35) LIMK1CDK5CDK5R1MAPK9MAPK10
SCHEMBL25663148 0.86 LIMK1 (0.38) LIMK1CDK5CDK5R1HTR2CHRH4
SCHEMBL25663161 0.85 LIMK1 (0.41) LIMK1CDK5CDK5R1HTR2CHRH4
SCHEMBL25663162 0.82 TDO2 (0.40) LIMK1CDK5CDK5R1TDO2HTR2C
SCHEMBL25663153 0.82 NPC1 (0.38) LIMK1CDK5CDK5R1HTR2CHRH4
SCHEMBL25663489 0.81 LIMK1 (0.35) LIMK1CDK5CDK5R1MAPK9MAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE CHRM1, CHRM2, CHRM4 LIMK1 1044/4885CDK5 1467/4885CDK5R1 1378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback